BMJ Best Practice

参考文献

关键文献

Castillo CG, Kauffman CA, Miceli MH. Blastomycosis. Infect Dis Clin North Am. 2016;30:247-264.

Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:1801-1812.

参考文章

1.  Castillo CG, Kauffman CA, Miceli MH. Blastomycosis. Infect Dis Clin North Am. 2016;30:247-264.

2.  Wheat LJ. Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis. 2006;8:128-139.

3.  Klein BS, Davis JP. A laboratory based surveillance of human blastomycosis in Wisconsin between 1973 and 1982. Am J Epidemiol. 1985;122:897-903.

4.  Habte-Gabr E, Smith IM. North American blastomycosis in Iowa: review of 34 cases. J Chronic Dis. 1973;26:585-594.

5.  Lowry PW, Kelso KY, McFarland LM. Blastomycosis in Washington, Parish, Louisiana, 1976-1985. Am J Epidemiol. 1989;130:151-159.

6.  Frye MD, Seifer FD. An outbreak of blastomycosis in eastern Tennessee. Mycopathologia. 1991;116:15-21.

7.  Crampton TL, Light RB, Berg GM, et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. Clin Infect Dis. 2002;34:1310-1316.

8.  Morris SK, Brophy J, Richardson SE, et al. Blastomycosis in Ontario, 1994-2003. Emerg Infect Dis. 2006;12:274-279.

9.  Klein BS, Vergeront JM, Davis JP. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect. 1986;1:29-39.

10.  Klein BS, Vergeront JM, DiSalvo AF, et al. Two outbreaks of blastomycosis along rivers in Wisconsin. Am Rev Respir Dis. 1987;136:1333-1338.

11.  Frean JA, Carman WF, Crew-Browne HH, et al. Blastomyces dermatitidis infections in the RSA. S Afr Med J. 1989;76:13-16.

12.  Carman WF, Frean JA, Crew-Browne HH, et al. Blastomycosis in Africa. Mycopathologia. 1989;107:25-32.

13.  Larone D. Medically important fungi, a guide to identification. Herdon, VA: ASM Press; 1995.

14.  Baumgardner DJ, Paretsky DP. The in vitro isolation of Blastomyces dermatitidis from a woodpile in north central Wisconsin, USA. Med Mycol. 1999;37:163-168.

15.  Brown EM, McTaggart LR, Zhang SX, et al. Phylogenetic analysis reveals a cryptic species Blastomyces gilchristii, sp. nov. within the human pathogenic fungus Blastomyces dermatitidis. PLoS One. 2013;8:e59237.

16.  Dukik K, Muñoz JF, Jiang Y, et al. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses. 2017;60:296-309.

17.  Bradsher RW, Chapman SW, Pappas PG. Blastomycosis. Infect Dis Clin N Am. 2003;17:21-40.

18.  Gray N, Baddour L. Cutaneous inoculation blastomycosis. Clin Infect Dis. 2002;34:e44-e49.

19.  Vaaler AK, Bradsher RW, Davies SF. Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin. Am J Med. 1990;89:470-476.

20.  Gauthier GM, Safdar N, Klein BS, et al. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis. 2007;9:310-317.

21.  Berger J, Zamora F, Podgaetz E, et al. Usefulness of lymphoid granulomatous inflammation culture obtained by endobronchial ultrasound-guided transbronchial needle aspiration in a fungal endemic area. Endosc Ultrasound. 2016;5:243-247.

22.  Taxy JB. Blastomycosis: contributions of morphology to diagnosis. Am J Surg Pathol. 2007;31:615-623.

23.  Babady NE, Buckwalter SP, Hall L, et al. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol. 2011;49:3204-3208.

24.  Sidamonidze K, Peck MK, Perez M, et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol. 2012;50:1783-1786.

25.  Frost HM, Novicki TJ. Blastomyces antigen detection for diagnosis and management of blastomycosis. J Clin Microbiol. 2015;53:3660-3662.

26.  National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis and histoplasmosis with ketoconazole. Ann Intern Med. 1985;103:861-872.

27.  Dismukes WE, Bradsher RW Jr, Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med. 1992;93:489-497.

28.  Pappas PG, Bradsher RW, Chapman SW, et al. Treatment of blastomycosis with fluconazole: a pilot study. Clin Infect Dis. 1995;20:267-271.

29.  Ta M, Flowers SA, Rogers PD. The role of voriconazole in the treatment of central nervous system blastomycosis. Ann Pharmacother. 2009;43:1696-1700.

30.  Freifeld A, Proia L, Andes D, et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother. 2009;53:1648-1651.

31.  Bariola JR, Perry P, Pappas PG, et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis. 2010;50:797-804.

32.  Limper AH, Knox KS, Sarosi GA, et al. American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183:96-128.

33.  Yamazaki T, Inagaki Y, Fujii T, et al. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan. Int J Antimicrob Agents. 2010;36:324-331.

34.  Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, et al. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin Infect Dis. 2016;63:356-362.

35.  Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:1801-1812.

36.  Chapman SW, Bradsher RW, Campbell GD, et al. Practice guidelines for the management of patients with blastomycosis. Clin Infect Dis. 2000;30:679-683.

37.  Hope WW, Billaud EM, Lestner J, et al. Therapeutic drug monitoring for triazoles. Curr Opin Infect Dis. 2008;21:580-586.

使用此内容应接受我们的免责声明